鼻咽癌调强放疗的回顾性剂量学研究:放射性脑干损伤与剂量-体积分析
该回顾性队列纳入2005年5月至2014年12月连续327例接受调强放疗的鼻咽癌患者,分析剂量-体积数据与长期结局。中位随访56个月,8例发生放射性脑干损伤,3年和5年发生率分别为2.2%和2.8%;Cox回归显示损伤与T4分期及GTVnx D2%、脑干Dmax、D1%、D0.1cc、D1cc相关(p<0.05),ROC曲线确定上述参数的剂量界值。
要点
- 327例鼻咽癌调强放疗后中位随访56个月,8例出现放射性脑干损伤,5年发生率为2.8%。
- 脑干损伤与T4分期及GTVnx D2%、脑干Dmax、D1%、D0.1cc、D1cc相关(p<0.05)。
- ROC曲线确定GTVnx D2%及脑干Dmax、D1%、D0.1cc、D1cc的剂量界值分别为77.26 Gy、67.85 Gy、60.13 Gy、60.75 Gy、54.58 Gy。
核心结论
- 接受根治性调强放疗的鼻咽癌患者中放射性脑干损伤不常见。
- 多种剂量-体积数据可能是放射性脑干损伤的剂量耐受参数。
研究设计与样本
- 回顾性分析2005年5月至2014年12月连续327例接受调强放疗的鼻咽癌患者的剂量-体积数据与长期结局。
主要发现
- 中位随访56个月(范围3-141个月),6例T4和2例T3患者发生放射性脑干损伤。
- 3年和5年放射性脑干损伤发生率分别为2.2%和2.8%。
- 脑干损伤潜伏期9至58个月,中位21个月。
- Cox回归显示脑干放射性毒性 associated with T4分期、GTVnx D2%、脑干Dmax、D1%、D0.1cc、D1cc(p<0.05)。
- ROC曲线显示GTVnx D2%及脑干Dmax、D1%、D0.1cc、D1cc为脑干损伤的显著预测因子,曲线下面积分别为0.724、0.813、0.818、0.818、0.798(p<0.001),界值分别为77.26 Gy、67.85 Gy、60.13 Gy、60.75 Gy、54.58 Gy。
关键数值与推荐
- GTVnx D2%的剂量界值为77.26 Gy。
- 脑干Dmax的剂量界值为67.85 Gy。
- 脑干D1%的剂量界值为60.13 Gy。
- 脑干D0.1cc的剂量界值为60.75 Gy。
- 脑干D1cc的剂量界值为54.58 Gy。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation therapy is the standard radical treatment for nasopharyngeal carcinoma (NPC) but also causes transient as well as long-term complications. Patients who develop severe radiation-induced brainstem injuries have a poor prognosis due to the lack of effective medical therapies. However, the relationship between brainstem injury and radiation volume dose is unknown. In this study, we found that radiation-induced brainstem injury was significantly associated with brainstem dose per unit volume. METHODS: A retrospective analysis was performed on a consecutive cohort of 327 patients with NPC receiving IMRT from May 2005 to December 2014. Dose-volume data and long-term outcome were analyzed. RESULTS: The median follow-up duration was 56 months (range, 3-141 months), and six with T4 and two with T3 patients had radiation-induced brainstem injuries. The 3-year and 5-year incidences were 2.2% and 2.8%, respectively. The latency period of brainstem injury ranged from 9 to 58 months, with a median period of 21 months. The Cox regression analysis showed that brainstem radiation toxicity was associated with the T4 stage, D2% of gross tumor volume of nasopharyngeal primary lesions and their direct extensions (GTVnx), Dmax (the maximum point dose), D1%, D0.1cc (the top dose delivered to a 0.1-ml volume), and D1cc (the top dose delivered to a 1-ml volume) of the brainstem (p < 0.05). Receiver operating characteristic (ROC) curves showed that GTVnx D2% and the Dmax, D1%, D0.1cc, and D1cc of the brainstem were significant predictors of brainstem injury. The area under the ROC curve for these five parameters was 0.724, 0.813, 0.818, 0.818, and 0.798, respectively (p < 0.001), and the cutoff points 77.26 Gy, 67.85 Gy, 60.13 Gy, 60.75 Gy, and 54.58 Gy, respectively, were deemed as the radiation dose limit. CONCLUSIONS: Radiotherapy-induced brainstem injury was uncommon in patients with NPC who received definitive IMRT. Multiple dose-volume data may be the dose tolerance of radiation-induced brainstem injury.
引用
- Yao CY, Zhou GR, Wang LJ, et al. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis. Radiat Oncol. 2018. PMID: 30285884. doi:10.1186/s13014-018-1105-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。